Press releases Image EN FR Proton Therapy / 04.03.2025 IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India Read more IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India
Press releases Image EN FR Proton Therapy / 06.02.2025 IBA signs Proteus®ONE system contract with AIG in Hyderabad, India Read more IBA signs Proteus®ONE system contract with AIG in Hyderabad, India
Press releases Image EN FR Corporate / 21.01.2025 IBA and Wallonie Entreprendre International secure 30% stake in mi2-factory to support improved efficiency of silicon carbide-powered devices Read more IBA and Wallonie Entreprendre International secure 30% stake in mi2-factory to support improved efficiency of silicon carbide-powered devices
Press releases Image EN FR Corporate / 17.01.2025 IBA announces Chief Financial Officer transition Read more IBA announces Chief Financial Officer transition
Press releases Image EN FR Corporate / 10.01.2025 Ensuring the continuity of IBA's Entrepreneurial Anchoring Read more Ensuring the continuity of IBA's Entrepreneurial Anchoring
Press releases Image EN FR Corporate / 05.12.2024 New generation steps up to continue IBA’s entrepreneurial ownership Read more New generation steps up to continue IBA’s entrepreneurial ownership
Press releases Image EN FR Corporate / 21.11.2024 IBA Business Update – Third Quarter 2024 Read more IBA Business Update – Third Quarter 2024
Press releases Image EN FR Industrial Solutions / 06.11.2024 IBA signs contract with SteriLab for E-beam sterilization solution in the Dominican Republic Read more IBA signs contract with SteriLab for E-beam sterilization solution in the Dominican Republic
Press releases Image EN FR Corporate / 11.09.2024 IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production Read more IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production
Reports Image EN FR Corporate / 29.08.2024 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2024 Read more UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS JUNE 30, 2024
Press releases Image EN FR Corporate / 29.08.2024 IBA Reports Half Year 2024 Results Read more IBA Reports Half Year 2024 Results
Press releases Image FR EN Proton Therapy / 27.08.2024 IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions Read more IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions
Press releases Image EN FR Corporate / 23.05.2024 IBA Business Update – First Quarter 2024 Read more IBA Business Update – First Quarter 2024
Press releases Image FR EN Proton Therapy / 02.05.2024 IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US Read more IBA signs contract with Yale New Haven Health and Hartford HealthCare to install Proteus®ONE proton therapy solution in Connecticut, US
Presentations Image EN Corporate / 21.03.2024 IBA Full Year 2023 Presentation Read more IBA Full Year 2023 Presentation
Press releases Image EN FR Corporate / 21.03.2024 IBA Reports Full Year 2023 Results Read more IBA Reports Full Year 2023 Results
Press releases Image EN FR Corporate / 08.02.2024 IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence Read more IBA acquires Radcal Corporation to expand Medical Imaging Quality Assurance offering and strengthen US presence
Press releases Image EN FR Proton Therapy / 21.12.2023 IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center Read more IBA signs contract for a Proteus®ONE proton therapy system to be located at the Greater Poland Cancer Center
Press releases Image EN FR CN Corporate / 16.11.2023 IBA Business Update – Third Quarter 2023 Read more IBA Business Update – Third Quarter 2023